Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Bristol Myers Squibb

US study suggests BMS’ cancer drug could target Parkinson’s-causing protein

US study suggests BMS’ cancer drug could target Parkinson’s-causing protein
p p Read More

The progressive neurodegenerative condition affects more than ten million people worldwide

June 20, 2024 Bristol Myers Squibb, Johns Hopkins Medicine, Lag3, neurodegenerative conditions, News, nivolumab/relatlimab, Opdualag, Parkinson's disease

Study suggests tumour microenvironments could predict cancer progression

NSCLC is the most common type of lung cancer and is responsible for up to 85% of all […]

April 12, 2024 Bristol Myers Squibb, Cancer Research UK, Francis Crick Institute, lung cancer, News, non-small cell lung cancer, Oncology, TRACERx, University College London

Cancer treatment could identify patients most likely to respond to cancer drugs

Tumours with high mtDNA mutations more likely to respond to Opdivo

February 1, 2024 Bristol Myers Squibb, Cancer Research UK, Cancer Research UK Scotland Institute, Memorial Sloan Kettering Cancer Centre, mitochondrial DNA mutations, News, nivolumab, Opdivo
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy